Source: SpaceDaily

Acucela: Acucela Signs Agreement to Develop a Compact OCT for NASA's Deep Space Missions

Seattle WA (SPX) Mar 19, 2019Acucela Inc has signed an agreement with the Translational Research Institute for Space Health (TRISH) to develop a compact OCT*1 device for NASA's Deep Space missions. Approximately 63% of long-duration spaceflight crewmembers present with one or more signs of Spaceflight Associated Neuro-ocular Syndrome (SANS), including optic disc edema, globe flattening, choroidal folds, cotton wool sp

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Ryo Kubota's photo - Chairman & CEO of Acucela

Chairman & CEO

Ryo Kubota

CEO Approval Rating

85/100

Read more